NASDAQ:ACAD Shareholder Notice: Lawsuit Alleges Misleading Statements by ACADIA Pharmaceuticals Inc
An investor, who purchased shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), filed a lawsuit against ACADIA Pharmaceuticals Inc over alleged violations of Federal Securities Laws.
View full press release